Atazanavir Sulfate CAS 229975-97-7 Purity ≥99.0% API Factory Anti-HIV HIV-1 Protease Inhibitor Featured Image

Atazanavir Sulfate CAS 229975-97-7 Purity ≥99.0% API Factory Anti-HIV-1 Protease Inhibitor

Inkcazelo emfutshane:

Igama leMichiza: Atazanavir Sulfate

I-CAS: 229975-97-7

Imbonakalo: I-White okanye i-Off-White Powder

Ubunyulu: ≥99.0%

HIV-1 Protease Inhibitor

Umgangatho ophezulu we-API, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ukubonelela ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
Igama leMichiza: Atazanavir Sulfate
I-CAS: 229975-97-7
HIV-1 Protease Inhibitor
Umgangatho ophezulu we-API, iMveliso yoRhwebo

Iipropati zeMichiza:

Igama leMchiza	Atazanavir sulfate
Izithethantonye	I-BMS-232632 Sulfate
Inombolo yeCAS	229975-97-7
Inombolo yeCAT	RF-API71
Ubume beStokhwe	Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli	C38H52N6O7.H2SO4
Ubunzima beMolekyuli	802.93
Indawo yokunyibilika	195.0 ~ 198.0℃
Ukunyibilika	Ayinyibiliki emanzini, iNyibilika kwi-DMSO
Ugcino Lwexesha elide	Gcina Ixesha elide kwi -20 ℃
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye oMhlophe
Sulfate	12.0 ~ 12.5%
Ilahleko ekomisweni	≤0.50%
Intsalela kwi-Ignition	≤0.10%
Iintsimbi ezinzima	≤20ppm
Ukungacoceki Okukodwa	≤0.30%
Ukungcola ngokupheleleyo	≤1.0%
Indlela yokuhlanjululwa / yoHlalutya	≥99.0% (HPLC)
pH	5.0~8.0
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	HIV-1 Protease Inhibitor Anti-HIV

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

FAQ:

Isicelo:

I-Atazanavir Sulfate (BMS-232632 Sulfate) (i-CAS: 229975-97-7) luhlobo lwetyuwa yesulfate ye-atazanavir ekhethwa kakhulu yi-HIV-1 protease inhibitor, yi-protease inhibitor yokuqala evunyiweyo ukuba ilawulwe kanye yonke imihla.I-Atazanavir Sulfate i-substrate kunye ne-inhibitor ye-CYP3A4, kunye ne-inhibitor kunye ne-inducer ye-P-glycoprotein (P-gp).I-Atazanavir Sulfate ikwayi-SARS-CoV 3CLpro inhibitor ene-IC50 ye-3.49 μM.I-Atazanavir Sulfate yi-azapeptide kunye ne-HIV-protease inhibitor esetyenziswa kunyango losulelo lwe-HIV kunye ne-AIDS ngokudibanisa nezinye ii-Anti-HIV Agents, iye yaphuhliswa kwaye yasungulwa yi-Bristol-Myers Squibb (BMS), phantsi kwelayisenisi yehlabathi evela kwi-Novartis, kunyango losulelo lwe-HIV.I-Atazanavir yasungulwa e-US njenge-Reyataz™ ngoJulayi 2003. I-Antiviral.I-Atazanavir ibonakalise ukuba namandla ngokubanzi kune-HIV-1 protease inhibitors ezivunyiweyo ngoku.I-Atazanavir inqanda ngokukhethekileyo ukusetyenzwa kwentsholongwane-ngqo kwintsholongwane yeGag kunye neGag-Pol polyprotein kwiiseli ezosulelekileyo ze-HIV-1 ngokuzibophelela kwindawo esebenzayo ye-HIV-1 protease, ngaloo ndlela ithintela ukwakheka kweeviriyoni ezivuthiweyo.I-Atazanavir ayisebenzi ngokuchasene ne-HIV-2.